Company: ANIX
Filing Date: 2025-09-10
Form Type: 10-Q
Source: 0001493152-25-013000
Chunk: 6

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
 2 
  
    Common
    stock issued pursuant to an employee stock purchase plan 
     1,518  
     -  
     4  
     -  
     -  
     4  
     -  
     4 
  
    Cancelation of treasury
    shares 
     (2,000) 
     -  
     (6) 
     -  
     6  
     -  
     -  
     - 
  
    Net
    loss 
     -  
     -  
     -  
     (8,232) 
     -  
     (8,232) 
     (74) 
     (8,306)
  
    Balance,
    July 31, 2025 
     32,822,109  
    $328  
    $265,249  
    $(248,982) 
    $-  
    $16,595  
    $(1,184) 
    $15,411 

FOR
THE NINE MONTHS ENDED JULY 31, 2024 (UNAUDITED)

    Common
    Stock  
    Additional  

    Total  
    Non-  

    Shares  
    Par
    Value  
    Paid-in
    Capital  
    Accumulated
    Deficit  
    Treasury
     Stock  
    Shareholders’
    Equity  
    controlling
    Interest  
    Total
    Equity 

    Balance,
    October 31, 2023 
     31,145,219  
    $311  
    $252,222  
    $(228,196) 
    $-  
    $24,337  
    $(966) 
    $23,371 
  
    Balance 
     31,145,219  
    $311  
    $252,222  
    $(228,196) 
    $-  
    $24,337  
    $(966) 
    $23,371 

    Stock
    option compensation to employees and directors 
     -  
     -  
     3,440  
     -  
     -  
     3,440  
     -  
     3,440